查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138321

ECMO（體外膜氧合器）全球市場-2022-2029

Global Extracorporeal Membrane Oxygenation Machine Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

肺癌患病率的上升、老年人口的增長以及 ECMO 技術的改進是推動 ECMO（體外膜氧合）全球市場發展的主要因素。

預計肺癌發病率的上升和老年人口的增加將推動市場增長。

體外膜氧合器市場 各種因素，如肺癌患病率上升、老年人口增加以及 ECMO 技術的改進，預計也將推動 ECMO 設備市場。

越來越多的 ECMO 中心、會議和培訓計劃旨在提高對該技術的認識，這也有助於市場的增長。此外，主要參與者提供技術先進的設備也有望在市場增長中發揮重要作用。

根據世界衛生組織的數據，慢性阻塞性肺病 (COPD) 影響著全球約 2 億人。目前，政府組織增加對慢性病治療的資金預計將推動市場增長。

例如，在歐盟，COPD 的直接費用約佔總醫療費用的 6%，佔呼吸系統疾病總費用的近 56%。推動體外膜氧合市場的還有 ECMO 技術在肺移植中的高采用率。因此，提高患者和醫院對體外膜肺氧合技術的認識將為市場參與者提供未來更好的機會。

與一些 ECMO（體外膜氧合器）相關的副作用和高成本預計會阻礙市場增長。

這些機器和這些處理的高成本是製約市場的主要因素。隨著時間的推移，這種治療既費時又費錢，因為許多醫療專業人員聯合起來監測和照顧病人。

行業分析

全球體外膜氧合器市場基於波特五力、監管分析、供應鏈分析、定價分析、未滿足的需求和產品創新等各種行業因素，提供了對市場的深入分析。

ECMO 全球市場報告提供大約 45 多個市場數據表、40 多個圖表和 180 頁內容。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 肺癌患病率上升和老年人口不斷增加
    • 限制
      • 一些 ECMO（體外膜氧合器）的高成本和副作用
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析
  • 未滿足的需求
  • 產品創新

第 6 章按模態類型

  • 靜脈動脈 (VA)
  • 靜脈曲張 (VV)
  • 動靜脈 (AV)

第 7 章按應用程序

  • 呼吸系統
  • 心
  • 體外心肺復蘇術 (ECPR)

第 8 章按組件

  • 泵
  • 氧氣機
  • 控制器
  • 套管
  • 配飾

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 11 章公司簡介

  • Medtronic plc.
  • MAQUET Holding B. V. & Co. KG
  • LivaNova PLC
  • XENIOS AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • NIPRO Corporation
  • OriGen Biomedical Inc
  • ALung Technologies Inc
  • EUROSETS S.r.l.

第12章 ECMO（體外膜氧合器）世界市場-DataM

簡介目錄
Product Code: DMMD2218

Market Overview

Extracorporeal Membrane Oxygenation Machine Market size was valued US$ 553 million in 2022 and is estimated to reach US$ 708 million by 2029, growing at a CAGR of 5.1% during the forecast period (2022-2029).

An extracorporeal membrane oxygenation machine also known as a life support machine is used in the treatment of various heart and lung diseases. The main purpose of an extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when the heart and lungs are not functioning properly. This machine is used worldwide for the treatment of lung cancer and chronic disorders.

Market Dynamics

Rising prevalence rates of lung cancer, increasing geriatric population, improvements in ECMO technology are the major factors driving the global extracorporeal membrane oxygenation machine market.

The increasing prevalence rates of lung cancer and increasing geriatric population are expected to drive the growth of market.

The extracorporeal membrane oxygenation machine market is driven by various factors such as rising prevalence rates of lung cancer, increasing geriatric population, improvements in ECMO technology are expected to be other driving forces for the ECMO machine market.

The growth of the market can also be attributed to the rising number of ECMO centres, conferences, and training programs to increase awareness about the technology. Moreover, the availability of technologically advanced devices by key players is also expected to play a vital role in the growth of the market.

According to the WHO, chronic obstructive pulmonary disease (COPD) affects nearly 200 million people globally. Today, rising funding by government organizations for the treatment of chronic diseases will boost market growth.

For instance, in European Union the direct cost of COPD is around 6% of total health expenditure, accounting for nearly 56% of the total cost of respiratory diseases. Another, driving factor for the extracorporeal membrane oxygenation market is the high adoption rate of ECMO techniques for lung transplantation. Thus, increasing awareness about extracorporeal membrane oxygenation techniques among the patients and in hospitals will provide market players with better opportunities in the future.

Adverse effects associated with some extracorporeal membrane oxygenation machine and high cost are expected to hamper the market growth.

The high cost of these machines and these therapies are the main factors responsible for the restraining of the market. This therapy takes a lot of time and many medical professionals team for observation and care of patient during the procedure this gradually increases the cost.

Industry Analysis

The global extracorporeal membrane oxygenation machine market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Unmet Needs, Product Innovations.

Segment Analysis

Application segment is expected to hold the largest market share in global Extracorporeal Membrane Oxygenation Machine market

Based on Modality, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Veno-arterial (VA), Veno-venous (VV), and Arterio-venous (AV). These modalities are used to provide hemodynamic support and to facilitate gaseous exchange in patients with cardiac or respiratory failure.

Among these, Veno-venous (VV) segment is expected to account for the largest share of the market in 2019. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements.

According to the U.S. National Institute of Health (NIH), a combination of veno-venous and veno-arterial is used in specific cases, such as cardiogenic shock. The veno-arterial segment led the market in 2019.

Veno-arterial systems can be used for the treatment/management of decreased cardiac output and tissue hypoperfusion, which results in cardiogenic shock. This can act as a trigger for a myocardial infarction or chronic ischemia.

Based on Application, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the Increasing number of people suffering from chronic diseases such as obesity and diabetes, highly susceptible to suffer from cardiovascular conditions will drive the extracorporeal cardiopulmonary resuscitation (ECPR) market.

Based on Component, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Pumps, Oxygenators, Controllers, Cannula, and Accessories.

Geographical Analysis

North America region holds the largest market share in the global extracorporeal membrane oxygenation machine market

North America is expected to account for the largest share of the global market in 2022, followed by Europe, Asia-Pacific, and the Rest of the World. The large share of North America is due to the well-developed primary, secondary, and tertiary care hospitals, reimbursement framework, favourable government funding, and higher awareness about the ECMO systems facilitating their adoption in hospitals.

On the other hand, Asia Pacific is expected to be the fastest-growing regional market over the forecast period. This can be attributed to the increasing prevalence of lung cancer in countries, such as China and India. According to National Cancer Centre (NCC), each year ~781,000 patients are diagnosed with lung cancer in China and is one of the leading causes of cancer deaths in the country.

Competitive Landscape

Some of the major manufacturers in the extracorporeal membrane oxygenation machine market are MAQUET Holding B. V. & Co. KG, Medtronic plc, LivaNova PLC. These companies together contributed XX% of the global market in 2019. The other players of the market are XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc, ALung Technologies Inc, and EUROSETS S.r.l.

The key players are adopting various growth strategies such as new product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Extracorporeal Membrane Oxygenation Machine market globally. For instance,

  • Terumo Cardiovascular Systems Corporation has made refinements in existing technology while manufacturing CAPIOX FX Oxygenator.
  • Medtronic Plc designed Minimax Plus Oxygen System with functions such as venous aerosols and low arterial ports, integrated into the system to enhance security and performance for patients (neonates and children).

Key Companies to Watch

Medtronic plc

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio:

NAUTILUS ECMO OXYGENATOR: This ECMO Oxygenator has a path of flowing that is transverse with circular profile. Transverse flow reduces the surface contact area as well as achieve lower blood side pressure drop. It is circular that removes the low flow and stasis that occur in corners.

Key Developments: In March 2020, Medtronic showed its portable ventilator design specifications, to speed up the global ventilator production.

The global extracorporeal membrane oxygenation machine market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing prevalence rates of lung cancer and increasing geriatric population
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost and adverse effects associated with some extracorporeal membrane oxygenation machine
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Regulatory Analysis
  • 5.3 Supply Chain Analysis
  • 5.4 Pricing Analysis
  • 5.5 Unmet Needs
  • 5.6 Product innovations

6. By Modality Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type Segment
    • 6.1.2. Market Attractiveness Index, By Modality Type Segment
  • 6.2. Veno-arterial (VA)
      • 6.2.1.1. Introduction
      • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Veno-venous (VV)
  • 6.4. Arterio-venous (AV)

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Respiratory
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Cardiac
  • 7.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR)

8. By Component

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Segment
    • 8.1.2. Market Attractiveness Index, By Component Segment
  • 8.2. Pumps
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Oxygenators
  • 8.4. Controllers
  • 8.5. Cannula
  • 8.6. Accessories

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Products Benchmarking
  • 10.4. List of Key Companies to Watch

11. Company Profiles

  • 11.1. Medtronic plc.

a. Company Overview

b. Product Portfolio and Description

c. Key Highlights

d. Financial Overview

  • 11.2. MAQUET Holding B. V. & Co. KG
  • 11.3. LivaNova PLC
  • 11.4. XENIOS AG
  • 11.5. Terumo Corporation
  • 11.6. MicroPort Scientific Corporation
  • 11.7. NIPRO Corporation
  • 11.8. OriGen Biomedical Inc
  • 11.9. ALung Technologies Inc
  • 11.10 EUROSETS S.r.l.

LIST NOT EXHAUSTIVE

12. Global Extracorporeal Membrane Oxygenation Machine Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Component
  • 12.3. Contact Us